Inventor · disambiguated record
Thomas Knappe
Also filed as: KNAPPE THOMAS
7 granted patents·9 pending applications·8 citations·filing 2012–2025
74Inventor score
Files withASCENDIS PHARMA AS10ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S3ASCENDIS PHARMA ONCOLOGY DIV A/S2ASCENDIS PHARMA GROWTH DISORDERS DIV AS1
Top patents by PatentIndex Score
16 records- 0179US11642415B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2019·Granted May 9, 2023·1 cites·28 claims
- 0274US12246070B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2023·Granted Mar 11, 2025·0 cites·4 claims
- 0373US10519226B2VEGF neutralizing prodrugs for the treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2013·Granted Dec 31, 2019·6 cites·21 claims
- 0466US2023116809A1Prevention and treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2022·Application pending·0 cites
- 0564US9855340B2Hydrogel prodrugsASCENDIS PHARMA AS·Filed 2013·Granted Jan 2, 2018·1 cites·44 claims
- 0663US2025255973A1Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0761US10040850B2Protecting group comprising a purification tagASCENDIS PHARMA AS·Filed 2014·Granted Aug 7, 2018·0 cites·14 claims
- 0858US2025387508A1Methods of producing hydrogel microspheresASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0951US2015010634A1Prevention and treatment of ocular conditionsASCENDIS PHARMA AS·Filed 2012·Application pending·0 cites
- 1051US2023340055A1Glycosylated il-2 proteins and uses thereofASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2021·Application pending·0 cites
- 1150US11116849B2Hydrogel-linked prodrugs releasing tagged drugsASCENDIS PHARMA AS·Filed 2014·Granted Sep 14, 2021·0 cites·27 claims
- 1250US2018312582A1Protecting Group Comprising a Purification TagASCENDIS PHARMA AS·Filed 2018·Application pending·0 cites
- 1349US2025387503A1Drug conjugates for the treatment of ocular disordersASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2025·Application pending·0 cites
- 1447US2017112939A1Prevention and treatment of ocular conditionsASCENDIS PHARMA GROWTH DISORDERS DIV AS·Filed 2017·Application pending·0 cites
- 1540US2022305136A1Anti-ctla4 conjugatesASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1637US11633487B2Prodrugs comprising an aminoalkyl glycine linkerASCENDIS PHARMA AS·Filed 2015·Granted Apr 25, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Knappe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →